• Alzamend Neuro held its annual shareholder meeting on April 17, 2026.
• Shareholders ratified Haskell & White LLP as independent registered public accounting firm for fiscal year ending April 30, 2026.
• Investors adopted Alzamend Neuro 2025 Stock Incentive Plan.
• Shareholders authorized an amendment to certificate of incorporation to permit a reverse stock split within a 1-for-2 to 1-for-10 range, with board set to choose exact ratio before April 16, 2027.
• Investors also authorized one or more meeting adjournments to allow additional proxy solicitation if needed to secure votes on other matters.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-004806), on April 17, 2026, and is solely responsible for the information contained therein.